VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 214 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2024. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $417,606 | -10.4% | 46,922 | +2.0% | 0.01% | 0.0% |
| Q1 2024 | $466,224 | +0.7% | 46,024 | -0.0% | 0.01% | 0.0% |
| Q4 2023 | $463,193 | +36.5% | 46,043 | +27.2% | 0.01% | +28.6% |
| Q3 2023 | $339,279 | -47.0% | 36,209 | +38.8% | 0.01% | -46.2% |
| Q2 2023 | $639,915 | +9.2% | 26,087 | +3.6% | 0.01% | +18.2% |
| Q1 2023 | $585,823 | +36.4% | 25,175 | +48.4% | 0.01% | +37.5% |
| Q4 2022 | $429,435 | +110.5% | 16,967 | +60.6% | 0.01% | +100.0% |
| Q3 2022 | $204,000 | -20.3% | 10,566 | +11.0% | 0.00% | +33.3% |
| Q4 2020 | $256,000 | – | 9,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |